Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease

BackgroundAs the most common neurodegenerative disease, Alzheimer’s disease (AD) leads to progressive loss of cognition and memory. Presently, the underlying pathogenic genes of AD patients remain elusive, and effective disease-modifying therapy is not available. This study explored novel biomarkers...

Full description

Bibliographic Details
Main Authors: Zhuohang Liu, Hang Li, Shuyi Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2021.658323/full
_version_ 1818623853194117120
author Zhuohang Liu
Zhuohang Liu
Hang Li
Shuyi Pan
Shuyi Pan
author_facet Zhuohang Liu
Zhuohang Liu
Hang Li
Shuyi Pan
Shuyi Pan
author_sort Zhuohang Liu
collection DOAJ
description BackgroundAs the most common neurodegenerative disease, Alzheimer’s disease (AD) leads to progressive loss of cognition and memory. Presently, the underlying pathogenic genes of AD patients remain elusive, and effective disease-modifying therapy is not available. This study explored novel biomarkers that can affect diagnosis and treatment in AD based on immune infiltration.MethodsThe gene expression profiles of 139 AD cases and 134 normal controls were obtained from the NCBI GEO public database. We applied the computational method CIBERSORT to bulk gene expression profiles of AD to quantify 22 subsets of immune cells. Besides, based on the use of the Least Absolute Shrinkage Selection Operator (LASSO), this study also applied SVM-RFE analysis to screen key genes. GO-based semantic similarity and logistic regression model analyses were applied to explore hub genes further.ResultsThere was a remarkable significance in the infiltration of immune cells between the subgroups. The proportions for monocytes, M0 macrophages, and dendritic cells in the AD group were significantly higher than those in the normal group, while the proportion of some cells was lower than that of the normal group, such as NK cell resting, T-cell CD4 naive, T-cell CD4 memory activation, and eosinophils. Additionally, seven genes (ABCA2, CREBRF, CD72, CETN2, KCNG1, NDUFA2, and RPL36AL) were identified as hub genes. Then we performed the analysis of immune factor correlation, gene set enrichment analysis (GSEA), and GO based on seven hub genes. The AUC of ROC prediction model in test and validation sets were 0.845 and 0.839, respectively. Eventually, the mRNA expression analysis of ABCA2, NDUFA2, CREBRF, and CD72 revealed significant differences among the seven hub genes and then was confirmed by RT-PCR.ConclusionA model based on immune cell infiltration might be used to forecast AD patients’ diagnosis, and it provided a new perspective for AD treatment targets.
first_indexed 2024-12-16T18:47:39Z
format Article
id doaj.art-0fa1160b8bcc46969b12c16bfce34567
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-16T18:47:39Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-0fa1160b8bcc46969b12c16bfce345672022-12-21T22:20:47ZengFrontiers Media S.A.Frontiers in Genetics1664-80212021-07-011210.3389/fgene.2021.658323658323Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s DiseaseZhuohang Liu0Zhuohang Liu1Hang Li2Shuyi Pan3Shuyi Pan4The Fifth Clinical Medical College of Anhui Medical University, Beijing, ChinaDepartment of Hyperbaric Oxygen, Sixth Medical Center, Chinese PLA General Hospital, Beijing, ChinaDepartment of Hyperbaric Oxygen, Sixth Medical Center, Chinese PLA General Hospital, Beijing, ChinaThe Fifth Clinical Medical College of Anhui Medical University, Beijing, ChinaDepartment of Hyperbaric Oxygen, Sixth Medical Center, Chinese PLA General Hospital, Beijing, ChinaBackgroundAs the most common neurodegenerative disease, Alzheimer’s disease (AD) leads to progressive loss of cognition and memory. Presently, the underlying pathogenic genes of AD patients remain elusive, and effective disease-modifying therapy is not available. This study explored novel biomarkers that can affect diagnosis and treatment in AD based on immune infiltration.MethodsThe gene expression profiles of 139 AD cases and 134 normal controls were obtained from the NCBI GEO public database. We applied the computational method CIBERSORT to bulk gene expression profiles of AD to quantify 22 subsets of immune cells. Besides, based on the use of the Least Absolute Shrinkage Selection Operator (LASSO), this study also applied SVM-RFE analysis to screen key genes. GO-based semantic similarity and logistic regression model analyses were applied to explore hub genes further.ResultsThere was a remarkable significance in the infiltration of immune cells between the subgroups. The proportions for monocytes, M0 macrophages, and dendritic cells in the AD group were significantly higher than those in the normal group, while the proportion of some cells was lower than that of the normal group, such as NK cell resting, T-cell CD4 naive, T-cell CD4 memory activation, and eosinophils. Additionally, seven genes (ABCA2, CREBRF, CD72, CETN2, KCNG1, NDUFA2, and RPL36AL) were identified as hub genes. Then we performed the analysis of immune factor correlation, gene set enrichment analysis (GSEA), and GO based on seven hub genes. The AUC of ROC prediction model in test and validation sets were 0.845 and 0.839, respectively. Eventually, the mRNA expression analysis of ABCA2, NDUFA2, CREBRF, and CD72 revealed significant differences among the seven hub genes and then was confirmed by RT-PCR.ConclusionA model based on immune cell infiltration might be used to forecast AD patients’ diagnosis, and it provided a new perspective for AD treatment targets.https://www.frontiersin.org/articles/10.3389/fgene.2021.658323/fullgenetic correlationAlzheimer diseaseimmune infiltrationbioinformatics analysisGSEA
spellingShingle Zhuohang Liu
Zhuohang Liu
Hang Li
Shuyi Pan
Shuyi Pan
Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
Frontiers in Genetics
genetic correlation
Alzheimer disease
immune infiltration
bioinformatics analysis
GSEA
title Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
title_full Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
title_fullStr Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
title_full_unstemmed Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
title_short Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
title_sort discovery and validation of key biomarkers based on immune infiltrates in alzheimer s disease
topic genetic correlation
Alzheimer disease
immune infiltration
bioinformatics analysis
GSEA
url https://www.frontiersin.org/articles/10.3389/fgene.2021.658323/full
work_keys_str_mv AT zhuohangliu discoveryandvalidationofkeybiomarkersbasedonimmuneinfiltratesinalzheimersdisease
AT zhuohangliu discoveryandvalidationofkeybiomarkersbasedonimmuneinfiltratesinalzheimersdisease
AT hangli discoveryandvalidationofkeybiomarkersbasedonimmuneinfiltratesinalzheimersdisease
AT shuyipan discoveryandvalidationofkeybiomarkersbasedonimmuneinfiltratesinalzheimersdisease
AT shuyipan discoveryandvalidationofkeybiomarkersbasedonimmuneinfiltratesinalzheimersdisease